세계의 의약품 안전성 시장 : 기능, 전달 모드, 최종 사용자별 예측(2025-2030년)

The Drug Safety Market was valued at USD 11.56 billion in 2023, expected to reach USD 14.06 billion in 2024, and is projected to grow at a CAGR of 21.70%, to USD 45.74 billion by 2030.

The drug safety market plays a critical role in the pharmaceutical industry, focused on ensuring the safety, efficacy, and quality of drugs by identifying, evaluating, and mitigating risks associated with their use. Drug safety is necessary to prevent adverse effects and ensure regulatory compliance, given the stringent guidelines worldwide for pharmaceuticals. The application scope ranges from pre-clinical trials to post-marketing surveillance, with end-users including pharmaceutical companies, regulatory authorities, healthcare providers, and patients. Key influencing growth factors include the rising prevalence of chronic diseases, increasing drug development activities, heightened regulatory requirements, and the adoption of advanced technologies such as AI and big data analytics in pharmacovigilance processes. However, the market faces limitations, including high costs associated with safety testing and compliance, complex regulatory landscapes, and time-consuming approval processes. Current opportunities lie in the expansion of personalized medicine, which requires more tailored drug safety evaluations, and the growing emphasis on patient-centric approaches that drive demand for real-time safety monitoring solutions. Companies can seize these opportunities by investing in innovative safety management solutions and partnerships to leverage technological advancements. Additionally, expanding into emerging markets, where healthcare infrastructure is rapidly developing, presents lucrative prospects. Innovation and research can focus on integrating machine learning and AI to streamline safety processes, predicting adverse outcomes more efficiently, and improving overall drug development timelines. Despite challenges, such as data privacy concerns and varying international regulations, the market is ripe for disruptive innovations that enhance safety protocols. As heightened scrutiny and transparency demands continue to shape this dynamic sector, staying ahead requires a keen focus on technological integration and strategic collaborations to drive market leadership and sustainable growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Drug Safety Market

The Drug Safety Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing population addicted to smoking
  • Escalating patient safety issues
  • Rise in demand for outsourcing services by players
• Market Restraints
  • Issues related to clinical trials
• Market Opportunities
  • Rising R&D activities
  • Increasing adoption of drug safety facilitating the launch of new drugs
• Market Challenges
  • Adverse effects of drugs

Porter's Five Forces: A Strategic Tool for Navigating the Drug Safety Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Drug Safety Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Drug Safety Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Drug Safety Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Drug Safety Market

A detailed market share analysis in the Drug Safety Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Drug Safety Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Drug Safety Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Drug Safety Market

A strategic analysis of the Drug Safety Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Drug Safety Market, highlighting leading vendors and their innovative profiles. These include AB CUBE S.A.S, Accenture, plc, ArisGlobal LLC, Cinven, Cognizant Technology Solutions Corp, Ergomed PLC, EXTEDO GmbH, Genpact, HCL Technologies Limited, Indigene Pharmaceuticals, Inc., IQVIA Inc., Medco Health Solutions, Inc., Oracle Corporation, Parexel International Corporation, PPD Inc, Sarjen Systems Pvt. Ltd, Sparta Systems Inc., Syneos Health, and Worldwide Clinical Trials.

Market Segmentation & Coverage

This research report categorizes the Drug Safety Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Functionality, market is studied across ADR Reporting, Drug Safety Audits, Fully Integrated Software, and Issue Tracking.
• Based on Delivery Mode, market is studied across On-Demand and On-Premise.
• Based on End User, market is studied across Business Process Outsourcing, Contract Research Organizations, and Pharma & Biotech Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing population addicted to smoking
    • 5.1.1.2. Escalating patient safety issues
    • 5.1.1.3. Rise in demand for outsourcing services by players
  • 5.1.2. Restraints
    • 5.1.2.1. Issues related to clinical trials
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising R&D activities
    • 5.1.3.2. Increasing adoption of drug safety facilitating the launch of new drugs
  • 5.1.4. Challenges
    • 5.1.4.1. Adverse effects of drugs
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Drug Safety Market, by Functionality

• 6.1. Introduction
• 6.2. ADR Reporting
• 6.3. Drug Safety Audits
• 6.4. Fully Integrated Software
• 6.5. Issue Tracking

7. Drug Safety Market, by Delivery Mode

• 7.1. Introduction
• 7.2. On-Demand
• 7.3. On-Premise

8. Drug Safety Market, by End User

• 8.1. Introduction
• 8.2. Business Process Outsourcing
• 8.3. Contract Research Organizations
• 8.4. Pharma & Biotech Companies

9. Americas Drug Safety Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Drug Safety Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Drug Safety Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AB CUBE S.A.S
• 2. Accenture, plc
• 3. ArisGlobal LLC
• 4. Cinven
• 5. Cognizant Technology Solutions Corp
• 6. Ergomed PLC
• 7. EXTEDO GmbH
• 8. Genpact
• 9. HCL Technologies Limited
• 10. Indigene Pharmaceuticals, Inc.
• 11. IQVIA Inc.
• 12. Medco Health Solutions, Inc.
• 13. Oracle Corporation
• 14. Parexel International Corporation
• 15. PPD Inc
• 16. Sarjen Systems Pvt. Ltd
• 17. Sparta Systems Inc.
• 18. Syneos Health
• 19. Worldwide Clinical Trials